Deviated and early unsustainable stunted development of gut microbiota in children with autism spectrum disorder
Mingxing Lou,Aihua Cao,Cuiyuan Jin,Kai Mi,Xiyue Xiong,Zhaoyang Zeng,Xu Pan,Jinlong Qie,Shangfeng Qiu,Yaofang Niu,Hao Liang,Yanping Liu,Lin Chen,Zhi Liu,Qing Zhao,Xiyan Qiu,Yuanxiang Jin,Xiaoqi Sheng,Zhibin Hu,Gulei Jin,Jingshi Liu,Xingyin Liu,Yichao Wang
DOI: https://doi.org/10.1136/gutjnl-2021-325115
IF: 24.5
2021-12-20
Gut
Abstract:Objective Recent studies have provided insights into the gut microbiota in autism spectrum disorder (ASD); however, these studies were restricted owing to limited sampling at the unitary stage of childhood. Herein, we aimed to reveal developmental characteristics of gut microbiota in a large cohort of subjects with ASD combined with interindividual factors impacting gut microbiota. Design A large cohort of 773 subjects with ASD (aged 16 months to 19 years), 429 neurotypical (NT) development subjects (aged 11 months to 15 years) were emolyed to determine the dynamics change of gut microbiota across different ages using 16S rRNA sequencing. Result In subjects with ASD, we observed a distinct but progressive deviation in the development of gut microbiota characterised by persistently decreased alpha diversity, early unsustainable immature microbiota, altered aboudance of 20 operational taxonomic units (OTUs), decreased taxon detection rate and 325 deregulated microbial metabolic functions with age-dependent patterns. We further revealed microbial relationships that have changed extensively in ASD before 3 years of age, which were associated with the severity of behaviour, sleep and GI symptoms in the ASD group. This analysis demonstrated that a signature of the combination of 2 OTUs, Veillonella and Enterobacteriaceae , and 17 microbial metabolic functions efficiently discriminated ASD from NT subjects in both the discovery (area under the curve (AUC)=0.86), and validation 1 (AUC=0.78), 2 (AUC=0.82) and 3 (AUC=0.67) sets. Conclusion Our large cohort combined with clinical symptom analysis highlights the key regulator of gut microbiota in the pathogenesis of ASD and emphasises the importance of monitoring and targeting the gut microbiome in future clinical applications of ASD.
gastroenterology & hepatology